# Safety Study of the VEGA UV-A System to Treat Ectasia

> **NCT01398839** · PHASE3 · TERMINATED · sponsor: **Topcon Medical Systems, Inc.** · enrollment: 103 (actual)

## Conditions studied

- Ectasia

## Interventions

- **DEVICE:** VEGA UV-A Illumination System
- **DRUG:** Riboflavin

## Key facts

- **NCT ID:** NCT01398839
- **Lead sponsor:** Topcon Medical Systems, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-12
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2022-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01398839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01398839, "Safety Study of the VEGA UV-A System to Treat Ectasia". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT01398839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*